Landscapes / Companies

Almirall, S.A. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
3 in Phase 2
Next date
LAD328, Phase 2 trial completes
Drugs
6
in active trials · 10 in all
Trials
8 active
23 since 2021

Drugs6

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Eli Lilly
Approved 25 Apr 2027Phase 3 trial completes
Microtubule inhibitor
Approved Jul 2027Phase 4 trial completes
—
Phase 2 Feb 2027Phase 2 trial completes
—
Phase 2 25 May 2027Phase 2 trial completes
—
Phase 2 23 Jun 2027Phase 2 trial completes
—
Phase 1 31 May 2027Phase 1 trial completes

About

No active trial
KX2-391 Ointment 1%, of KX2-391 Ointment 1%, Pidotimod, Tirbanibulin ointment 1%
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Almirall, S.A.

Following is part of Solo: you see every change to Almirall, S.A. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in